New style

events
Conference
October 10, 2017
**Moscow, Russia October 10, 2017** – **InSysBio LLC**, one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for the drug development, announced a renewal of the corporate identity. >“Lately we have become more successful and have grown bigger. We are expanding our business and are attracting new customers and partners. And now we need to become more vivid and recognizable. That is why rebranding of the company is a logical step”, Oleg Demin Jr, the head of Business Development, spoke about the reasons for such changes. >“The official name InSysBio is now short and memorable. A new symbol is a cell made of gear-wheels. It shows that we consider the living organism and its processes as parts of the mechanism that is accurately described in our models and platforms. Corporate colors are just the employees’ favorite colors. It's so important to surround yourself with what you like and do what you love”, Oleg explained the meanings of attributes of the corporate identity. You can meet the new InSysBio in a week at the eighth American Conference on Pharmacometrics (ACoP8), to be held from October 15th to October 18th, 2017. The meeting will take place at the Marriott Resort: Harbor Beach Hotel, Fort Lauderdale, Florida. See InSysBio ACoP8 [Agenda here](http://insilicobio.ru/share/ACoP8_agenda.pdf). Don’t miss our exhibition **booth #4**.
September 2021
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1. 23 Sep 2021 16:14 InSysBio to participate in SITC 2021 InSysBio announces its participation in SITC's 36th Annual Meeting & Pre-Conference Programs (the Society for Immunotherapy of Cancer) which to be held November 10th to 14th, 2021 in person in Washington, DC, and virtually. InSysBio expert modeler Oleg Demin Jr and his student Elena Vasileva are going to present a poster
24
25
26
27
28
29
30
   
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
Tags
Latest News
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling